References
- McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 1998;105:3S–9S
- Friedewald JrVE, Bennett JS, Packer M, et al. The editor’s round table: nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol 2008;102:1046–55
- Kienzler JL, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol 2010;50:50–61
- Barthel HR, Haselwood D, Longley 3rdS, et al. Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum 2009;39:203–12
- Galer BS. A comparative subjective assessment study of PENNSAID(R) and Voltaren Gel(R), two topical formulations of diclofenac sodium. Pain Pract 2011;11:252–60
- Radermacher J, Jentsch D, Scholl MA, et al. Diclofenac concentrations in synovial fluid and plasma after cutaneous application in inflammatory and degenerative joint disease. Br J Clin Pharmacol 1991;31:537–41
- Miyatake S, Ichiyama H, Kondo E, Yasuda K. Randomized clinical comparisons of diclofenac concentration in the soft tissues and blood plasma between topical and oral applications. Br J Clin Pharmacol 2009;67:125–9
- Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ 2004;329:324–9
- Rautio J, Taipale H, Gynther J, et al. In vitro evaluation of acyloxyalkyl esters as dermal prodrugs of ketoprofen and naproxen. J Pharm Sci 1998;87:1622–8
- Valiveti S, Paudel KS, Hammell DC. In vitro/in vivo correlation of transdermal naltrexone prodrugs in hairless guinea pigs. Pharm Res 2005;22:981–9
- Guy R, Hadgraft J. Transdermal drug delivery. 2nd ed. New York: Marcel Dekker Inc.; 2003
- Abo-Ghalia MH, Shalaby AM, el-Eraqi WI, Awad HM. Synthesis and anti-phlogistic potency of some new non-proteinogenic amino acid conjugates of “Diclofenac”. Amino Acids 1999;16:425–40
- Halen PK, Murumkar PR, Giridhar R, Yadav MR. Prodrug designing of NSAIDs. Mini Rev Med Chem 2009;9:124–39
- Ribeiro L, Silva N, Iley J. Aminocarbonyloxymethyl ester prodrugs of flufenamic acid and diclofenac: suppressing the rearrangement pathway in aqueous media. Arch Pharm (Weinheim) 2007;340:32–40
- Bonina FP, Puglia C, Barbuzzi T. In vitro and in vivo evaluation of polyoxyethylene esters as dermal prodrugs of ketoprofen, naproxen and diclofenac. Eur J Pharm Sci 2001;14:123–34
- Jilani J, Shatnawi A, Idkaidek N. Evaluation of hydroxyethyldiclofenac as possible prodrug for topical application. Acta Pharma Turcica 2003;45:227–33
- Peck KD, Ghanem AH, Higuchi WI. The effect of temperature upon the permeation of polar and ionic solutes through human epidermal membrane. J Pharm Sci 1995;84:975–82
- Doh HJ, Cho WJ, Yong CS. Synthesis and evaluation of Ketorolac ester prodrugs for transdermal delivery. J Pharm Sci 2003;92:1008–17
- He N, Li SK, Suhonen TM, et al. Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin. J Pharm Sci 2003;92:297–310
- Yan G, Xu Q, Anissimov YG, et al. Alternating current (AC) iontophoretic transport across human epidermal membrane: effects of AC frequency and amplitude. Pharm Res 2008;25:616–24